Syntrix analgesic overcomes tramadol’s dependence on CYP2D6

Syntrix is creating desmetramadol as a safer and less variable version of tramadol

Bypassing the metabolic conversion required for Schedule IV opiate tramadol to achieve analgesia, Syntrix has positioned desmetramadol as a safer and more effective pain therapy.

Tramadol has been positioned as less likely to cause lethal respiratory depression than other opioids,

Read the full 392 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers